A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Radiation Oncology Residency Program Bookmark and Share

Radiation Oncology Residency Program

The City of Hope Radiation Oncology Residency Program is a four-year Accreditation Council for Graduate Medical Education (ACGME) accredited program which begins in the PGY-2 year. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research. The program emphasizes preparation for careers in academic radiation oncology. The selection process gives preference to those applicants who show an aptitude for academic medicine and with an interest in teaching, research and the application of cutting-edge translational technologies to cancer care.

Training is provided in clinical radiation oncology, treatment planning, radiation physics, and radiobiology, equipping graduates to provide comprehensive patient care as practicing radiation oncologists either in academia or the private practice setting. Residents actively participate in the management of a diverse variety of patients, with progressively increasing responsibilities during later phases of the Program. The attending physicians and the resident physicians work as a team, with the resident assuming primary care responsibilities for patients under the attending’s supervision. The resident-attending teams evaluate and counsel new patients and provide treatment which includes radiotherapy simulation, treatment planning, and administration of irradiation. The resident physician follows the patient throughout treatment with attending supervision and subsequently in post-radiotherapy follow-up clinics.

Please refer to Resident Handbook for complete outline of Program Year Objectives.

The total complement of residents is four, with one resident currently being accepted per year into the program. The program participates in the National and Resident Matching Program, with applications processed through the Electronic Residency Application Service (ERAS) common application program. (Refer to Application Process for more information)

City of Hope continues to be on the forefront of the latest treatment technology and clinical research, providing residents with a rich and comprehensive training environment. As an NCI designated comprehensive cancer center and charter member of the NCCN, City of Hope provides an excellent environment for residency education. A major and extensive renovation is underway that will increase the clinical area to 29,000 square feet with 4 treatment vaults, 3 imaging suites, a new clinic area and expansion of treatment planning and physics work space. Two Tomotherapy units, a Varian Trilogy and Varian IX will be installed. Multimodality functional tumor imaging will be a key part of the new center which will house MRI, PET/CT and CT units dedicated to treatment planning and treatment response assessment. In addition to these resources, radiation biology labs occupying a total of 4-5000 square feet currently house the labs of 4 NCI funded basic lab scientists. Finally an additional 8000 square feet is dedicated to an established radioimmunotherapy program with basic science laboratories and a radiopharmacy for the labeling of preclinical and clinical radiopharmaceuticals for tumor imaging and targeted tumor therapy.

Formal lectures cover radiation biology, physics, and clinical radiation oncology. clinical trial design, biostatistics, imaging (PET, SPECT, MRI,etc.), medical oncology and pediatric oncology. Multidisciplinary training will be emphasized. City of Hope has established fellowship programs in medical oncology, hematologic oncology, pathology, surgery, and urology. Ample interaction occurs through clinical conferences and tumor boards. Electives will be available with the other oncologic specialties.

Each resident will also be required to do an 8-12 month research rotation. He or she will select a lab or clinical research project to pursue, with the goal of publishing at least 2 manuscripts in peer-reviewed journals.

In accordance with the American Board of Radiology (ABR) for board eligibility, City of Hope requires successful completion of a clinical PGY1 year in the United States prior to commencing its four-year Radiation Oncology Residency Program.
 
 
Using leading edge technology, the Department of Radiation Oncology offers specialized services in external beam radiation therapy, radioactive seed implantation for prostate cancer, stereotactic radiosurgery and image guided intensity modulated radiation therapy. We also offer novel approaches to cancer therapy, such as radioimmunotherapy and helical tomotherapy. Through innovative laboratory and clinical research programs, we continue to investigate ways to further advance the efficacy and safety of radiation therapy.

Application Process

How to Apply
 
 
Application Checklist
 
  • ERAS application
  • Official college, graduate school and medical school transcripts
  • An official record of board scores (NBME, FLEX, USMLE, LMCC, COMLEX, VQE or FMGEMS).
  • A dean's letter and two other letters of recommendation.
  • A curriculum vita.
  • A personal statement.
 
 
Graduates from a medical school outside of the United States or Canada must submit a valid ECFMG certificate.

Applications for each academic year, which begins July 1, should be completed by December 1 of the previous calendar year. If you are selected for an interview, you will be invited to visit City of Hope for an interview with selected faculty. Interviews are conducted from late November through early February each year.
 
Contact
 
For further information, contact the program by phone or email:
 
Thalia Yaden
Residency Program Coordinator
City of Hope Department of Radiation Oncology
1500 E. Duarte Road, Duarte, CA 91010
Telephone: 626-301-8247, ext. 64163
radiationresident@coh.org
 

Faculty

In addition to caring for patients in their clinical practices, the City of Hope Department of Radiation Oncology faculty members are committed to teaching and facilitating the growth of medical knowledge.

Faculty members in the Department of Radiation Oncology include:
 
Radiation Oncologists:
 
  • Jeffrey Wong, M.D., FASTRO Chair
 
  • Eric Radany, M.D., Ph.D., Program Director
 
  • Richard Pezner, M.D.
 
  • Nayana Vora, M.D.
 
  • Yi-Jen Chen, M.D., Ph.D.
 
  • Khanh Nguyen, M.D.
 
  • Andrew Raubitschek, M.D. (Radioimmunotherapy)
 
 
 
Physicist:
 
  • Timothy Schultheiss, Ph.D. FACR, FAAPM, FASTRO, Director of Radiation Physics Cecil Staud, Ph.D.
 
  • An Liu, Ph.D.
 
  • Chun-Hui Han, Ph.D.
 
  • Sean Sun, M.S.
 
  • Lawrence Williams, Ph.D., FACR (Diagnostic Imaging)
 
  • James Bading, Ph.D. (Radioimmunotherapy)
 
 
 
Radiation Biology
 
  • Binghui Shen, Ph.D., Director, Radiation Biology
 
  • Jeremy Stark, Ph.D.
 
  • Fong-Fong Chu, Ph.D.
 

Facility and Department

City of Hope is recognized worldwide for its compassionate patient care, innovative science and translational research, which rapidly turns laboratory breakthroughs into promising new therapies. We are one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers nationwide and a founding member of the National Comprehensive Cancer Network. 
 
On our park-like campus just northeast of Los Angeles, City of Hope Helford Clinical Research Hospital brings groundbreaking research and compassionate care under one roof. It embodies our mission to deliver the newest, most promising therapies to patients without delay, while creating an environment that encourages open collaboration between physicians, caregivers and clinical researchers.
 
City of Hope Department of Radiation Oncology treats more than 900 patients each year. The department is equipped with state-of-the art technology, with facility renovation underway.  The department offers the full spectrum of radiation therapy modalities, including:
 
  • External beam radiation therapy with high-energy photons and electrons.
  • 3-D Conformal Radiation Therapy
  • IMRT -- Intensity Modulated Radiation Therapy
  • IGRT -- Image Guided Radiation Therapy
  • Stereotactic Radiosurgery
  • Total Body and Total Marrow Irradiation in conjunction with a Bone Marrow Transplant
  • Brachytherapy with LDR and HDR techniques
  • Treatment with Unsealed Sources, including targeted radiopharmaceuticals and radio-immunotherapy
 
 

Therapy Equipment 
 
  • Two Helical TomoTherapy – IGRT units
  • One Varian 21EX dual energy (6 MeV and 10 MeV), MLC linear accelerators with multiple electron capability and IMRT
  • One 6 MeV Varian linear accelerators.
  • Varian high dose-rate afterloader for interstitial and intracavitary implants.
  • Variety of low dose-rate sources available for implantation.
  • Ultrasound guided equipment for permanent prostate seed implants. Equipment to be added soon
  • One Varian Trilogy dual energy with CBCT/OBI and SRS/SRT capable.
  • One Varian iX dual energy accelerator with CBCT/OBI
 
Planning / Verification Equipment
 
  • Large bore CT-Simulation unit, dedicated for treatment planning
  • One Varian conventional simulator
  • Varian Eclipse Treatment Planning System
  • TomoTherapy Treatment Planning System
  • IMPAC Radiation Oncology Management System
 
Planning Equipment to be added soon
 
  • GE multi slice PET/CT simulator dedicated to planning and response assessment
  • GE 1.5T MRI dedicated to radiation oncology planning and response assessment
 
Conferences
Residents will be required to attend various radiation oncology conferences each week, as well as multidisciplinary conferences. An integrated, multidisciplinary approach to patient management is stressed. 
 
Multidisciplinary clinics or tumor boards occur in breast cancer; GU/prostate cancer, sarcomas, head and neck cancers; pediatric cancers; gynecological malignancies; gastrointestinal cancers; central nervous system cancers; and lymphomas. There is frequent interaction between all specialties which care for these patients including medical oncology, pediatric oncology, general surgery, head and neck surgery, the bone marrow transplantation service, pain service, neurosurgery, gynecological oncologists, thoracic surgery, and other ancillary services. 
 
Residents are a vital and important part of this multidisciplinary approach to the treatment of patients with cancer.
 

Radiation Oncology Residency Program

Radiation Oncology Residency Program

The City of Hope Radiation Oncology Residency Program is a four-year Accreditation Council for Graduate Medical Education (ACGME) accredited program which begins in the PGY-2 year. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research. The program emphasizes preparation for careers in academic radiation oncology. The selection process gives preference to those applicants who show an aptitude for academic medicine and with an interest in teaching, research and the application of cutting-edge translational technologies to cancer care.

Training is provided in clinical radiation oncology, treatment planning, radiation physics, and radiobiology, equipping graduates to provide comprehensive patient care as practicing radiation oncologists either in academia or the private practice setting. Residents actively participate in the management of a diverse variety of patients, with progressively increasing responsibilities during later phases of the Program. The attending physicians and the resident physicians work as a team, with the resident assuming primary care responsibilities for patients under the attending’s supervision. The resident-attending teams evaluate and counsel new patients and provide treatment which includes radiotherapy simulation, treatment planning, and administration of irradiation. The resident physician follows the patient throughout treatment with attending supervision and subsequently in post-radiotherapy follow-up clinics.

Please refer to Resident Handbook for complete outline of Program Year Objectives.

The total complement of residents is four, with one resident currently being accepted per year into the program. The program participates in the National and Resident Matching Program, with applications processed through the Electronic Residency Application Service (ERAS) common application program. (Refer to Application Process for more information)

City of Hope continues to be on the forefront of the latest treatment technology and clinical research, providing residents with a rich and comprehensive training environment. As an NCI designated comprehensive cancer center and charter member of the NCCN, City of Hope provides an excellent environment for residency education. A major and extensive renovation is underway that will increase the clinical area to 29,000 square feet with 4 treatment vaults, 3 imaging suites, a new clinic area and expansion of treatment planning and physics work space. Two Tomotherapy units, a Varian Trilogy and Varian IX will be installed. Multimodality functional tumor imaging will be a key part of the new center which will house MRI, PET/CT and CT units dedicated to treatment planning and treatment response assessment. In addition to these resources, radiation biology labs occupying a total of 4-5000 square feet currently house the labs of 4 NCI funded basic lab scientists. Finally an additional 8000 square feet is dedicated to an established radioimmunotherapy program with basic science laboratories and a radiopharmacy for the labeling of preclinical and clinical radiopharmaceuticals for tumor imaging and targeted tumor therapy.

Formal lectures cover radiation biology, physics, and clinical radiation oncology. clinical trial design, biostatistics, imaging (PET, SPECT, MRI,etc.), medical oncology and pediatric oncology. Multidisciplinary training will be emphasized. City of Hope has established fellowship programs in medical oncology, hematologic oncology, pathology, surgery, and urology. Ample interaction occurs through clinical conferences and tumor boards. Electives will be available with the other oncologic specialties.

Each resident will also be required to do an 8-12 month research rotation. He or she will select a lab or clinical research project to pursue, with the goal of publishing at least 2 manuscripts in peer-reviewed journals.

In accordance with the American Board of Radiology (ABR) for board eligibility, City of Hope requires successful completion of a clinical PGY1 year in the United States prior to commencing its four-year Radiation Oncology Residency Program.
 
 
Using leading edge technology, the Department of Radiation Oncology offers specialized services in external beam radiation therapy, radioactive seed implantation for prostate cancer, stereotactic radiosurgery and image guided intensity modulated radiation therapy. We also offer novel approaches to cancer therapy, such as radioimmunotherapy and helical tomotherapy. Through innovative laboratory and clinical research programs, we continue to investigate ways to further advance the efficacy and safety of radiation therapy.

Application Process

Application Process

How to Apply
 
 
Application Checklist
 
  • ERAS application
  • Official college, graduate school and medical school transcripts
  • An official record of board scores (NBME, FLEX, USMLE, LMCC, COMLEX, VQE or FMGEMS).
  • A dean's letter and two other letters of recommendation.
  • A curriculum vita.
  • A personal statement.
 
 
Graduates from a medical school outside of the United States or Canada must submit a valid ECFMG certificate.

Applications for each academic year, which begins July 1, should be completed by December 1 of the previous calendar year. If you are selected for an interview, you will be invited to visit City of Hope for an interview with selected faculty. Interviews are conducted from late November through early February each year.
 
Contact
 
For further information, contact the program by phone or email:
 
Thalia Yaden
Residency Program Coordinator
City of Hope Department of Radiation Oncology
1500 E. Duarte Road, Duarte, CA 91010
Telephone: 626-301-8247, ext. 64163
radiationresident@coh.org
 

Faculty

Faculty

In addition to caring for patients in their clinical practices, the City of Hope Department of Radiation Oncology faculty members are committed to teaching and facilitating the growth of medical knowledge.

Faculty members in the Department of Radiation Oncology include:
 
Radiation Oncologists:
 
  • Jeffrey Wong, M.D., FASTRO Chair
 
  • Eric Radany, M.D., Ph.D., Program Director
 
  • Richard Pezner, M.D.
 
  • Nayana Vora, M.D.
 
  • Yi-Jen Chen, M.D., Ph.D.
 
  • Khanh Nguyen, M.D.
 
  • Andrew Raubitschek, M.D. (Radioimmunotherapy)
 
 
 
Physicist:
 
  • Timothy Schultheiss, Ph.D. FACR, FAAPM, FASTRO, Director of Radiation Physics Cecil Staud, Ph.D.
 
  • An Liu, Ph.D.
 
  • Chun-Hui Han, Ph.D.
 
  • Sean Sun, M.S.
 
  • Lawrence Williams, Ph.D., FACR (Diagnostic Imaging)
 
  • James Bading, Ph.D. (Radioimmunotherapy)
 
 
 
Radiation Biology
 
  • Binghui Shen, Ph.D., Director, Radiation Biology
 
  • Jeremy Stark, Ph.D.
 
  • Fong-Fong Chu, Ph.D.
 

Facility and Department

Facility and Department

City of Hope is recognized worldwide for its compassionate patient care, innovative science and translational research, which rapidly turns laboratory breakthroughs into promising new therapies. We are one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers nationwide and a founding member of the National Comprehensive Cancer Network. 
 
On our park-like campus just northeast of Los Angeles, City of Hope Helford Clinical Research Hospital brings groundbreaking research and compassionate care under one roof. It embodies our mission to deliver the newest, most promising therapies to patients without delay, while creating an environment that encourages open collaboration between physicians, caregivers and clinical researchers.
 
City of Hope Department of Radiation Oncology treats more than 900 patients each year. The department is equipped with state-of-the art technology, with facility renovation underway.  The department offers the full spectrum of radiation therapy modalities, including:
 
  • External beam radiation therapy with high-energy photons and electrons.
  • 3-D Conformal Radiation Therapy
  • IMRT -- Intensity Modulated Radiation Therapy
  • IGRT -- Image Guided Radiation Therapy
  • Stereotactic Radiosurgery
  • Total Body and Total Marrow Irradiation in conjunction with a Bone Marrow Transplant
  • Brachytherapy with LDR and HDR techniques
  • Treatment with Unsealed Sources, including targeted radiopharmaceuticals and radio-immunotherapy
 
 

Therapy Equipment 
 
  • Two Helical TomoTherapy – IGRT units
  • One Varian 21EX dual energy (6 MeV and 10 MeV), MLC linear accelerators with multiple electron capability and IMRT
  • One 6 MeV Varian linear accelerators.
  • Varian high dose-rate afterloader for interstitial and intracavitary implants.
  • Variety of low dose-rate sources available for implantation.
  • Ultrasound guided equipment for permanent prostate seed implants. Equipment to be added soon
  • One Varian Trilogy dual energy with CBCT/OBI and SRS/SRT capable.
  • One Varian iX dual energy accelerator with CBCT/OBI
 
Planning / Verification Equipment
 
  • Large bore CT-Simulation unit, dedicated for treatment planning
  • One Varian conventional simulator
  • Varian Eclipse Treatment Planning System
  • TomoTherapy Treatment Planning System
  • IMPAC Radiation Oncology Management System
 
Planning Equipment to be added soon
 
  • GE multi slice PET/CT simulator dedicated to planning and response assessment
  • GE 1.5T MRI dedicated to radiation oncology planning and response assessment
 
Conferences
Residents will be required to attend various radiation oncology conferences each week, as well as multidisciplinary conferences. An integrated, multidisciplinary approach to patient management is stressed. 
 
Multidisciplinary clinics or tumor boards occur in breast cancer; GU/prostate cancer, sarcomas, head and neck cancers; pediatric cancers; gynecological malignancies; gastrointestinal cancers; central nervous system cancers; and lymphomas. There is frequent interaction between all specialties which care for these patients including medical oncology, pediatric oncology, general surgery, head and neck surgery, the bone marrow transplantation service, pain service, neurosurgery, gynecological oncologists, thoracic surgery, and other ancillary services. 
 
Residents are a vital and important part of this multidisciplinary approach to the treatment of patients with cancer.
 
Fellowships and Residencies
City of Hope offers a number of exciting fellowships and residencies in laboratory cancer and diabetes research, administration, clinical applications and other areas.

City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Students and professionals at City of Hope can access a plethora of medical databases, scientific journals, course materials, special collections, and other useful resources at our 12,000 square foot Lee Graff Library.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • September is Prostate Cancer Awareness Month. Here, Bertram Yuh, M.D., assistant clinical professor in the Division of Urology and Urologic Services at City of Hope, explains the importance of understanding the risk factors for the disease and ways to reduce those risks, as well as overall prostate health. “Wha...
  • ** Learn more about prostate health, plus prostate cancer research and treatment, at City of Hope. ** Learn more about getting a second opinion at City of Hope by visiting us online or by calling 800-826-HOPE (4673). City of Hope staff will explain what’s required for a consult at City of Hope and help yo...
  • Childhood cancer survival rates have increased dramatically over the past 40 years. More than 80 percent of children with cancer now survive five years or more, which is a tremendous feat. Despite the survival rate increase, cancer continues to be the No. 1 disease killer and second-leading cause of death in ch...
  • Although a stem cell transplant can be a lifesaving procedure for people diagnosed with a blood cancer or blood disorder, the standard transplant may not be appropriate for all patients. This is because the conditioning regimen (the intensive chemotherapy and/or radiation treatments preceding the transplant) is...
  • Brain tumor removal would seem to be the obvious course of action in the wake of a brain tumor diagnosis, but that’s not always the case. Some tumors are too difficult for many surgeons to reach or too close to areas that control vital functions. Removing them just proves too risky. A new device being con...
  • Hijacking the same sorts of viruses that cause HIV and using them to reprogram immune cells to fight cancer sounds like stuff of the future. Some scientists believe that the future is closer than we think – and are now studying the approach in clinical trials at City of Hope. Immunotherapy is a promising approa...
  • Jennifer Linehan, M.D., an assistant clinical professor in City of Hope’s Division of Urology and Urologic Oncology in Antelope Valley, thought she knew all there was to know about treating prostate cancer. Then her father was diagnosed with the disease. This is her story. ** My father is 69 years old, has no h...
  • Nausea is the one of the most well-known, and dreaded, side effects of cancer treatment — and with good reason. Beyond the quality-of-life issues that it causes, severe nausea can prevent patients from receiving enough nutrients and calories at a time when they need every edge they can get. A few simple actions...
  • With Labor Day just around the corner, summer is on its way out. But just because summertime is ending doesn’t mean we can skip sunscreen. Protection from ultraviolet (UV) radiation is needed all year round. Exposure to UV radiation — whether from the sun or from artificial sources such as sunlamps used i...
  • Undergoing reconstructive surgery may seem like a forgone conclusion for survivors of breast cancer, but that doesn’t appear to be the case. A new study has found that most breast cancer survivors who undergo a mastectomy decide against surgical reconstruction of their breasts. The reasons for such a deci...
  • Nearly four decades ago, City of Hope began its bone marrow transplant program. Its first transplant reunion celebration was a single patient and his donor, also his brother. This year, City of Hope welcomed hundreds of hematopoietic cell transplant (HCT) recipients to the annual bone marrow transplant/HCT reun...
  • The burgeoning type 2 diabetes epidemic casts a pall over the health of America’s public. New research now shows the looming threat is getting worse. Much worse. A diabetes trends study published earlier this month in the Lancet Diabetes and Endocrinology by researchers at the federal Centers for Disease Contro...
  • An aspirin a day might help keep breast cancer away for some breast cancer survivors, a new study suggests. Obese women who have had breast cancer could cut their risk of a recurrence in half if they regularly take aspirin or other nonsteroidal anti-inflammatory drugs, called NSAIDs, report researchers from the...
  • Christine Crews isn’t only a fitness enthusiast, she’s also a personal trainer and fitness instructor. Being active defines her life. So when she was diagnosed with bladder cancer at age 30, she decided she absolutely couldn’t let the disease interfere with that lifestyle. And it didn’t. For t...
  • Cancer treatment and the cancer itself can cause changes in your sense of taste or smell. These side effects typically subside after treatment ends, but there are ways to help alleviate those bitter and metallic tastes in your mouth. Here are tips from the National Cancer Institute to help keeps tastes and food...